|
Information about 'OrALert™ Oral Fluid Drug Screen Device' |
Click to enlarge.
|
The OrALert™ Oral Fluid Drug Screen Device is a patent-pending method for the simultaneous, non-invasive detection of multiple drugs in human oral fluid.
Its cutting edge design allows for the use of our proprietary technology which enables the sensitive detection of parent THC without the need for buffers.
In addition, the design supports on-site specimen collection, thereby eliminating the need for third-party controlled collection sites altogether!
Collection site fees are widely considered one of the most expensive components of drug testing.
The OrALert™ Oral Fluid Drug Screen Device eliminates the need for special equipment, same-gender collectors and complicated training.
The test can be performed on-site anytime and offers immediate results.
The test is a multi-drug, multi-line, lateral flow chromatographic immunoassay for the qualitative detection of multiple drugs and/or their metabolites in oral fluid based on the principle of competitive binding.
Benefits of Oral Fluid Testing vs. other Drug Testing methods
1. No more urine!
2. Observed collections without donor privacy issues
3. Sensitive and specific assays
4. Non-invasive
5. Eliminates need for same-gender sample collection
6. No more collection site costs
7. Testing integrity (difficult to adulterate)
8. Results available in 10 minutes- allows for immediate hiring or treatment decisions
9. No additional equipment or operator training required
10. Complete test kit includes all components for testing including an easy-to-follow procedure card to help eliminate potential procedural errors
-----------------
The OrALert™ Oral Fluid Drug Screen Device for AMP/MAMP/COC/OPI/THC/PCP is an immunoassay based on the principle of competitive binding. Drugs that may be present in the oral fluid specimen compete against their respective drug conjugate for binding sites on their specific antibody.
During testing, a portion of the oral fluid specimen migrates upward by capillary action. A drug, if present in the oral fluid specimen below its cut-off concentration, will not saturate the binding sites of its specific antibody.
The antibody will then react with the drug-protein conjugate and a visible colored line will appear in the test region of the specific drug strip. The presence of drug above the cut-off concentration in the oral fluid specimen will saturate all the binding sites of the antibody. Therefore, no colored line will form in the test region.
A drug-positive oral fluid specimen will not generate a colored line in the specific test region of the strip because of drug competition, while a drug-negative oral fluid specimen will generate a line in the test region because of the absence of drug competition.
To serve as a procedural control, a colored line will always appear at the control region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.
|
|
